ICI Clinical Trials

3 actively recruiting trials

▲ +1 trial since August 2026

Also known as: Immune checkpoint inhibitors

Pipeline

Phase 1: 1

Top Sponsors

UMC Utrecht1
Guangzhou University of Traditional Chinese Medicine1
Groupe Hospitalier Pitie-Salpetriere1

Indications

Cancer2
Pericarditis1
Heart Disease1
Vasculitis1
Cardiovascular Diseases1

Other3 trials

Efficacy and Safety of HGXJT in Bone Metastatic NSCLC Patients

N/A

JOint Use of Database to Identify Risk Factors of CARDio-vascular Toxicity Induced by Immune Checkpoint Inhibitors

Treatment of Cancer With Immune Checkpoint Inhibition Therapy Boosted by High Intensity Focused Ultrasound Histotripsy

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.